Neuraptive Therapeutics
PrivateLast Round
Series B
Oct 14, 2022
Est. Valuation
$149.5M
Total Funding Raised
$32M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Neuraptive Therapeutics is a biotechnology company that develops novel therapeutics and medical products to improve outcomes for peripheral nerve injuries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neuraptive Therapeutics Comparables
Compare Neuraptive Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioCircuit Technologies | 82% | |
| Regenity Biosciences | 79% | |
| Axogen Inc | 79% | |
Neuraptive Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 14, 2022 | ||||
| Series A | Dec 19, 2018 | ||||
| Seed | Sep 6, 2017 |
Key People
Founding team and executive leadership
Neuraptive Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Benjamin Franklin Technology Partners | Series A |
| New Rhein Healthcare Investors | Series A |
| Central Texas Angel Network | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2026
Monthly visitors increased 99% MoM to 1.7K.
- Apr 16, 2026
Monthly visitors increased 30% MoM.
Neuraptive Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neuraptive Therapeutics's valuation, stock price, and market status.